These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

799 related items for PubMed ID: 27044423

  • 1. Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1.
    Ebefors K, Liu P, Lassén E, Elvin J, Candemark E, Levan K, Haraldsson B, Nyström J.
    BMC Nephrol; 2016 Apr 05; 17():40. PubMed ID: 27044423
    [Abstract] [Full Text] [Related]

  • 2. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 3. Sialylation of IgG inhibits the formation of galactose-deficient IgA1-containing immune complexes and protects mesangial cells from injury in IgA nephropathy.
    Liu Y, Li H, Yu H, Wang F, Jia J, Yan T.
    BMC Nephrol; 2022 Jan 11; 23(1):25. PubMed ID: 35016642
    [Abstract] [Full Text] [Related]

  • 4. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
    Tissandié E, Morelle W, Berthelot L, Vrtovsnik F, Daugas E, Walker F, Lebrec D, Trawalé JM, Francoz C, Durand F, Moura IC, Paradis V, Moreau R, Monteiro RC.
    Kidney Int; 2011 Dec 11; 80(12):1352-63. PubMed ID: 21866091
    [Abstract] [Full Text] [Related]

  • 5. IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells.
    Novak J, Raskova Kafkova L, Suzuki H, Tomana M, Matousovic K, Brown R, Hall S, Sanders JT, Eison TM, Moldoveanu Z, Novak L, Novak Z, Mayne R, Julian BA, Mestecky J, Wyatt RJ.
    Nephrol Dial Transplant; 2011 Nov 11; 26(11):3451-7. PubMed ID: 21828345
    [Abstract] [Full Text] [Related]

  • 6. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
    Tamouza H, Chemouny JM, Raskova Kafkova L, Berthelot L, Flamant M, Demion M, Mesnard L, Paubelle E, Walker F, Julian BA, Tissandié E, Tiwari MK, Camara NO, Vrtovsnik F, Benhamou M, Novak J, Monteiro RC, Moura IC.
    Kidney Int; 2012 Dec 11; 82(12):1284-96. PubMed ID: 22951891
    [Abstract] [Full Text] [Related]

  • 7. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep 11; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 8. The combined role of galactose-deficient IgA1 and streptococcal IgA-binding M Protein in inducing IL-6 and C3 secretion from human mesangial cells: implications for IgA nephropathy.
    Schmitt R, Ståhl AL, Olin AI, Kristoffersson AC, Rebetz J, Novak J, Lindahl G, Karpman D.
    J Immunol; 2014 Jul 01; 193(1):317-26. PubMed ID: 24850720
    [Abstract] [Full Text] [Related]

  • 9. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells.
    Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J.
    Kidney Int; 2005 Feb 01; 67(2):504-13. PubMed ID: 15673298
    [Abstract] [Full Text] [Related]

  • 10. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Feb 01; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 11. Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy.
    Kaneko Y, Otsuka T, Tsuchida Y, Gejyo F, Narita I.
    Int Immunol; 2012 Apr 01; 24(4):219-32. PubMed ID: 22298882
    [Abstract] [Full Text] [Related]

  • 12. Clinical Significance of Galactose-Deficient IgA1 by KM55 in Patients with IgA Nephropathy.
    Zhang K, Li Q, Zhang Y, Shang W, Wei L, Li H, Gao S, Yan T, Jia J, Liu Y, Lin S.
    Kidney Blood Press Res; 2019 Apr 01; 44(5):1196-1206. PubMed ID: 31574506
    [Abstract] [Full Text] [Related]

  • 13. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.
    Tamouza H, Vende F, Tiwari M, Arcos-Fajardo M, Vrtovsnik F, Benhamou M, Monteiro RC, Moura IC.
    Contrib Nephrol; 2007 Apr 01; 157():144-7. PubMed ID: 17495453
    [Abstract] [Full Text] [Related]

  • 14. Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy.
    Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H.
    Clin Immunol; 2020 Aug 01; 217():108483. PubMed ID: 32479989
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr 01; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
    Cambier A, Gleeson PJ, Abbad L, Canesi F, da Silva J, Bex-Coudrat J, Deschênes G, Boyer O, Rabant M, Ulinski T, Hogan J, Peuchmaur M, Berthelot L, Monteiro RC.
    Kidney Int; 2022 Feb 01; 101(2):274-287. PubMed ID: 34756952
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.